The Make-Or-Break Moment For Novavax: What To Watch In Third-Quarter EarningsInvestors Business Daily • 11/08/22
Novavax says Phase 3 trial of omicron-targeting COVID vaccine supports its use as a boosterMarket Watch • 11/08/22
Novavax Phase 3 COVID-19 Omicron Trial Supports the Continued and Future Use of Novavax Prototype Vaccine as a BoosterPRNewsWire • 11/08/22
Novavax to Host Conference Call to Discuss Third Quarter 2022 Financial Results and Operational Highlights on November 8, 2022PRNewsWire • 11/01/22
Novavax (NVAX) to Report Q3 Results: Wall Street Expects Earnings GrowthZacks Investment Research • 10/27/22
These Are the Five Best and Worst Performing Small-cap Stocks in September 202224/7 Wall Street • 10/22/22
Why Novavax's Uphill Battle Continues Despite Winning U.S. Booster AuthorizationInvestors Business Daily • 10/19/22
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster for AdultsPRNewsWire • 10/19/22